Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Journal of Medicinal Chemistry|March 24, 2016
Ten Years of Medicinal Chemistry (2005-2014) in the Journal of Medicinal Chemistry: Country of Contributors, Topics, and Public-Private PartnershipsLuca Costantino, Daniela BarloccoCurrent Medicinal Chemistry|November 17, 2004
Inhibitors for proteins endowed with catalytic and non-catalytic activity which recognize pTyrLuca Costantino, Daniela BarloccoFuture Medicinal Chemistry|April 1, 2015
New perspectives on the development of antiobesity drugsLuca Costantino, Daniela BarloccoFuture Medicinal Chemistry|March 24, 2011
Ghrelin receptor modulators and their therapeutic potentialLuca Costantino, Daniela BarloccoCurrent Medicinal Chemistry|February 7, 2006
Privileged structures as leads in medicinal chemistryLuca Costantino, Daniela BarloccoExpert Opinion on Therapeutic Patents|July 23, 2014
Ghrelin receptor modulators: a patent review (2011 - 2014)Luca Costantino, Daniela BarloccoCurrent Medicinal Chemistry|May 14, 2008
STAT 3 as a target for cancer drug discoveryLuca Costantino, Daniela BarloccoCurrent Medicinal Chemistry|June 10, 2016
Iron Acquisition Pathways as Targets for Antitubercular DrugsFiorella Meneghetti, Stefania Villa, Arianna Gelain, et al.Current Opinion in Investigational Drugs (London, England : 2000)|June 18, 2003
Insulin detemir. Novo NordiskDaniela BarloccoCurrent Opinion in Investigational Drugs (London, England : 2000)|December 3, 2003
Insulin glulisine. Aventis PharmaDaniela BarloccoPageof 8